Costs and outcomes of “intermediate” vs “minimal” care for youth‐onset type 1 diabetes in six countries

Data are needed to demonstrate that providing an “intermediate” level of type 1 diabetes (T1D) care is cost‐effective compared to “minimal” care in less‐resourced countries. We studied these care scenarios in six countries.

[1]  E. Vardell.  Global Health Observatory Data Repository , 2020, Medical reference services quarterly.

[2]  J. V. von Oettingen,et al.  Levels of type 1 diabetes care in children and adolescents for countries at varying resource levels , 2018, Pediatric diabetes.

[3]  L. Prosser,et al.  What are the clinical, quality-of-life, and cost consequences of 30 years of excellent vs. poor glycemic control in type 1 diabetes? , 2018, Journal of diabetes and its complications.

[4]  L. Prosser,et al.  The 30-year cost-effectiveness of alternative strategies to achieve excellent glycemic control in type 1 diabetes: An economic simulation informed by the results of the diabetes control and complications trial/epidemiology of diabetes interventions and complications (DCCT/EDIC). , 2018, Journal of diabetes and its complications.

[5]  D. Maahs,et al.  ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes , 2018, Pediatric diabetes.

[6]  C. Cannon,et al.  Professional Practice Committee: Standards of Medical Care in Diabetes—2018 , 2017, Diabetes Care.

[7]  A. Jenkins,et al.  Incidence and Mortality Rates and Clinical Characteristics of Type 1 Diabetes among Children and Young Adults in Cochabamba, Bolivia , 2017, Journal of diabetes research.

[8]  Marta Indulska,et al.  Open data: Quality over quantity , 2017, Int. J. Inf. Manag..

[9]  G. Ashuntantang,et al.  Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. , 2017, The Lancet. Global health.

[10]  M. Silink,et al.  The IDF Life for a Child Program Index of diabetes care for children and youth , 2016, Pediatric diabetes.

[11]  A. Jenkins,et al.  Financial costs for families of children with Type 1 diabetes in lower‐income countries , 2016, Diabetic medicine : a journal of the British Diabetic Association.

[12]  E. Rodgers.  Making fair choices on the path to universal health coverage , 2015 .

[13]  O. Norheim,et al.  Making fair choices on the path to universal health coverage. , 2014, Bulletin of the World Health Organization.

[14]  J. McGill,et al.  Evidence of a Strong Association Between Frequency of Self-Monitoring of Blood Glucose and Hemoglobin A1c Levels in T1D Exchange Clinic Registry Participants , 2013, Diabetes Care.

[15]  T. Orchard,et al.  Predictors of and survival after incident stroke in type 1 diabetes , 2013, Diabetes & vascular disease research.

[16]  A. Moran,et al.  Improved glycemic control and acute complications among children with type 1 diabetes mellitus in Moshi, Tanzania , 2012, Pediatric diabetes.

[17]  E. Strotmeyer,et al.  The assessment of clinical distal symmetric polyneuropathy in type 1 diabetes: a comparison of methodologies from the Pittsburgh Epidemiology of Diabetes Complications Cohort. , 2011, Diabetes research and clinical practice.

[18]  Rachel A. Nugent,et al.  The Burden of Chronic Kidney Disease on Developing Nations: A 21st Century Challenge in Global Health , 2011, Nephron Clinical Practice.

[19]  Z. Abbas,et al.  Challenges for management of the diabetic foot in Africa: doing more with less , 2007, International wound journal.

[20]  Thira,et al.  International Society for Pediatric and Adolescent Diabetes (ISPAD) , 2007 .

[21]  R. Klein,et al.  The 30-Year Natural History of Type 1 Diabetes Complications , 2006, Diabetes.

[22]  Anderson,et al.  An estimation of the economic impact of chronic noncommunicable diseases in selected countries , 2006 .

[23]  M. D. de Courten,et al.  Access to care for patients with insulin-requiring diabetes in developing countries: case studies of Mozambique and Zambia. , 2005, Diabetes care.

[24]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .

[25]  B. Rosner,et al.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents , 2004 .

[26]  National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents , 2004, Pediatrics.

[27]  T. Edejer,et al.  Generalized cost-effectiveness analysis for national-level priority-setting in the health sector , 2003, Cost effectiveness and resource allocation : C/E.

[28]  K. Forrest,et al.  Insulin resistance-related factors, but not glycemia, predict coronary artery disease in type 1 diabetes: 10-year follow-up data from the Pittsburgh Epidemiology of Diabetes Complications Study. , 2003, Diabetes care.

[29]  K. Forrest,et al.  Glycemia (or, in women, estimated glucose disposal rate) predict lower extremity arterial disease events in type 1 diabetes. , 2002, Metabolism: clinical and experimental.

[30]  The Look Ahead Research Group.  The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT) , 1998 .

[31]  V. Kadirkamanathan.  The effect of intensive diabetes therapy on measures of autonomic nervous system function in the Diabetes Control and Complications Trial (DCCT) , 1998, Diabetologia.

[32]  L. Kuller,et al.  Prevalence of Complications in IDDM by Sex and Duration: Pittsburgh Epidemiology of Diabetes Complications Study II , 1990, Diabetes.

[33]  Nancy Carlson,et al.  Clinical Procedures for Ocular Examination , 1990 .

[34]  E. Avner,et al.  Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. , 1989, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[35]  D. Wagener,et al.  The Pittsburgh Study of Insulin-Dependent Diabetes Mellitus: Risk for Diabetes Among Relatives of IDDM , 1982, Diabetes.

[36]  D. Ellis,et al.  New approach to evaluation of proteinuric states. , 1977, Clinical chemistry.